AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05966298 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Standart Rehabilitation
Description: This treatment includes shoulder exercises and conventional therapy (Infrared, ultrasound, TENS).
Study NCT05966298 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standart Rehabilitation
Description: This treatment includes shoulder exercises and conventional therapy (Infrared, ultrasound, TENS).
Study NCT05579639 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Xylitol
Description: Xylitol wipes
Study NCT05579639 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo wipes
Study NCT05237141 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etonogestrel implant
Description: Implant insertion in second menstrual cycle prior to ovulation
Study NCT04952259 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Shexiang Tongxin Dropping Pills + routine treatment
Description: oral+percutaneous coronary intervention
Study NCT04952259 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: routine treatment
Description: percutaneous coronary intervention
Study NCT05294952 — intervention group
Intervention type: GENETIC
Group type: EXPERIMENTAL
Intervention: real time PCR
Description: diagnostic test
Study NCT05821049 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: UPI65 (Low Dose)
Description: Red colored Capsules
Study NCT05821049 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: UP165 (High Dose)
Description: Red colored Capsules
Study NCT05821049 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Red colored Capsules
Study NCT06445413 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tai Chi
Description: Ten weekly 60-minute Tai Chi classes
Study NCT02819713 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: ultrasound gel
Study NCT02819713 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Instillagel
Study NCT05760599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Candonilimab
Description: 10mg/kg, iv.drip, every 3 week
Study NCT05760599 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: 15mg/kg, iv.drip, every 3 week
Study NCT05931263 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: C-BEAM Regimen
Description: Chidemide，carmustine, etoposide, cytarabine, and melphalan
Study NCT05931263 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: BEAM Regimen
Description: carmustine, etoposide, cytarabine, and melphalan
Study NCT04845230 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: FreshRx Nourishing Healthy Starts
Description: This is a field experiment study that incorporates referrals to public programs, food supplementation and nutrition education, or integrative care services provided by a Licensed Masters Social Worker.
Study NCT04845230 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FreshRx Nourishing Healthy Starts
Description: This is a field experiment study that incorporates referrals to public programs, food supplementation and nutrition education, or integrative care services provided by a Licensed Masters Social Worker.
Study NCT05590338 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK1070806
Description: Participants will receive GSK1070806
Study NCT05590338 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Participants will receive placebo
Study NCT05457725 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Contingent rtfMRI neurofeedback training
Description: Contingent rtfMRI neurofeedback training will follow an alternating up-regulation/rest block design with screen-color cues. Visual feedback about real-time brain activity in the ROI will be provided (e.g., via a thermometer bar). During resting blocks, the thermometer bar remains static.
Study NCT05457725 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Non-contingent/sham rtfMRI neurofeedback training
Description: Non-contingent/sham rtfMRI neurofeedback training will follow an alternating up-regulation/rest block design with screen-color cues. Visual feedback about non-contingent/sham brain activity in the ROI will be provided (e.g., via a thermometer bar). During resting blocks, the thermometer bar remains static.
Study NCT04732065 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ONC206
Description: Given orally (PO)
Study NCT04732065 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Standard of Care Radiation Therapy
Description: Undergo RT
Study NCT04732065 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Optional Proton (1H) MR spectroscopy (MRS)
Description: Optional imaging procedure
Study NCT03559816 — intervention group
Intervention type: OTHER
Intervention: Classification of perineal tears based on new classification
Description: Classifications according to the American College of Obstetricians and Gynaecologists (ACOG) and the Royal College of Obstetricians and Gynaecologists (RCOG) and sub classification of second-degree lacerations based on the assumption that episiotomy involves the same anatomic structures of a second-degree laceration (perineal muscle, mucosa and skin), and divides them in two sub-groups, named A (if spontaneous vaginal tear is smaller than episiotomy) and B (if spontaneous vaginal tear is bigger than episiotomy).
Study NCT03559816 — intervention group
Intervention type: PROCEDURE
Intervention: Selective use of Episiotomy
Description: Standardized selective use of Episiotomy as recommended by guidelines.
Study NCT05966233 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: R-DHAP
Description: * Rituximab 375 mg/m2 IV on D0 or D1~* Dexamethasone 40 mg/day IV or PO on D1-4~* Ara-C 2 g/m2 IV on D2 (2 doses every 12h) or D2 and D3~* Cisplatin 100 mg/ m2 IV on D1
Study NCT05966233 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pola-R-DHAP
Description: * Polatuzumab Vedotin 1.8 mg/kg IV on D1~* Rituximab 375 mg/m2 IV on D0 or D1~* Dexamethasone 40 mg/day IV or PO on D1-4~* Ara-C 2 g/m2 IV on D2 (2 doses every 12h) or D2 and D3~* Cisplatin 100 mg/ m2 IV on D1
Study NCT04775030 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CBD occlusal appliance
Description: Occlusal appliance manufactured with CBD molecules released from material to patients oral cavity during sleep time
Study NCT04775030 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Acrylic resin occlusal appliance
Description: Acrylic resin occlusal appliance during sleep time
Study NCT06019572 — intervention group
Intervention type: PROCEDURE
Intervention: Spine decompression and fixation surgery
Description: Surgery is performed by either an anterior or posterior approach. Anterior approach is performed with either discectomy or corpectomy accompanied fusion, while the posterior approach consist in a bilateral laminectomy accompanied by fusion.
Study NCT06157229 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MAT
Description: The protocol consists of four phases: 1) immobilization phase, 2) early protective phase, 3) intermediate phase and 4) late phase. The detailed guideline can be found in the following article:~Gaunt, B. W., Shaffer, M. A., Sauers, E. L., Michener, L. A., McCluskey, G. M., \& Thigpen, C. A. (2010). The American Society of Shoulder and Elbow Therapists' Consensus Rehabilitation Guideline for Arthroscopic Anterior Capsulolabral Repair of the Shoulder. Journal of Orthopaedic \& Sports Physical Therapy, 40(3), 155-168. https://doi.org/10.2519/jospt.2010.3186
Study NCT06157229 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: CABRR
Description: The protocol consists of four phases: 1) immobilization phase, 2) early phase, 3) intermediate phase and 4) advanced phase.~The protocol comprises education, modified cognitive behavioral therapy, neuromuscular control exercises, kinetic chain exercises, range of motion enhancing exercises, strength and conditioning exercises, and sport-specific exercises. The protocol is currently unpublished.
Study NCT05618223 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Description: Dapagliflozin 10 mg once daily in addition to standard therapy
Study NCT05730426 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Deep dry needling
Description: Method to decrease pain and improve function in musculoskeletal disorders.
Study NCT05730426 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Muscle energy technique
Description: Method to decrease pain and improve function in musculoskeletal disorders.
Study NCT05730426 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Neck stability exercise
Description: Method to decrease pain and improve function in musculoskeletal disorders.
Study NCT05107661 — intervention group
Intervention type: BEHAVIORAL
Intervention: Telephone Prompt
Description: Scripted messaging to remind subjects to complete their colorectal screening (colonoscopy or fecal test)
Study NCT05470452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The reading process is assisted by ENDOANGEL
Description: Diagnosis of benign and malignant lesions with the help of ENDOANGEL
Study NCT05470452 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: No ENDOANGEL assistance during the reading process
Description: Diagnosis of benign and malignant lesions without the help of ENDOANGEL
Study NCT05602389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VL-G-A57
Description: Dose: 700mg daily Route: Oral Regimen: 2 capsules in the morning with food and 2 capsules in the evening with food Duration: 60 days
Study NCT05602389 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: VL-G-E12
Description: Dose: 700mg daily Route: Oral Regimen: 2 capsules in the morning with food and 2 capsules in the evening with food Duration: 60 days
Study NCT05602389 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Dose: 700mg daily Route: Oral Regimen: 2 capsules in the morning with food and 2 capsules in the evening with food Duration: 60 days
Study NCT06298669 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Biventricular Pacing
Description: The CRT device will be reprogrammed to coordinate contractions of the left and right ventricles.
Study NCT06298669 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Right Ventricular Pacing
Description: The CRT device will be reprogrammed for right ventricular contractions.
Study NCT05772273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azacitidine
Description: Azacitidine 75 mg/m2 subcutaneously once daily on days 1-7.
Study NCT05772273 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Donor lymphocyte infusion
Description: The 4 DLI doses (dose range: ±10%) of sib-matched donor HSCT patients were 1×10\^6/kg, 5×10\^6/kg, 1×10\^7/kg, 5×10\^7/kg; The 4 DLI doses (dose range: ±10%) of haploidentical or unrelated donor HSCT patients were 1×10\^5/kg, 5×10\^5/kg, 1×10\^6/kg, 5×10\^6/kg.
Study NCT05772273 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camrelizumab
Description: Camrelizumab 200mg Q2W for sib-matched donor HSCT patients, 100mg Q2W for haploidentical or unrelated donor HSCT patients.
Study NCT05586802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Anastrozole
Description: This will be an experimental treatment for 26 weeks in Group 1 Arm A and Arm B as well for Group 2 Arm D
Study NCT05586802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Semaglutide
Description: This will be an experimental treatment for 26 weeks in Group 2 Arm E
Study NCT05586802 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: human chorionic gonadotropin
Description: This will be an experimental treatment for 26 weeks in addition to anastrozole in Group 1 - Arm B
Study NCT05586802 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Testosterone gel
Description: This will be an active comparator for 26 weeks in Group 2 - Arm C
Study NCT05574517 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Without reverse insertion of a ureteral catheter
Description: Traditional tubeless percutaneous nephrolithotomy usually need retrograde ureteral catheter insertion. Our intervention is that the tubeless percutaneous nephrolithotomy is executed without reverse insertion of a ureteral catheter.
Study NCT05397691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Modified Family Talk
Description: The Modified Family Talk intervention consists of six modules, each lasting approximately 60 minutes. Family Talk is intended to be delivered over a period of 12 weeks, with meetings occurring every 1-2 weeks.
Study NCT06377423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Direct technique
Description: The composite was placed directly using free-hand technique
Study NCT06377423 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Indirect technique
Description: The ceramic was placed using indirect method via laboratory casts
Study NCT05397691 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control-like parameter estimation
Description: Parameter estimation is designed to emulate best practices around comprehensive, high quality, patient-centered care for adults and youth. Participants will have access to collaborative adult Office Based Addiction Treatment (OBAT) clinical services, multidisciplinary adolescent primary care clinics with co-located adolescent substance use specialists, high quality social work services, integrated behavioral health, and access to patient navigators for assistance connecting to community resources.
Study NCT04831073 — intervention group
Intervention type: PROCEDURE
Intervention: Surgery on the ascending aorta with or without repair of the aortic root and/or aortic arch
Description: Surgical repair of the ascending aorta with or without surgical repair of the aortic root and/or aortic arch
Study NCT05145140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Standardized Western Medicine Treatment
Description: Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Study NCT05145140 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standardized Western Medicine Treatment
Description: Standardized Western Medicine Treatment includes hypoglycemic, debridement and anti infection treatments.
Study NCT05519865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tucidinostat
Description: 30mg orally BIW
Study NCT05145140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tangningtongluo tablet and cream
Description: Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.There are two dosage forms: tablet and cream.
Study NCT05145140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tangningtongluo tablet
Description: Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use tablet.
Study NCT05145140 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tangningtongluo cream
Description: Tangningtongluo(TNTL) , a traditional botanical ethnic medicine, composed of plantain, honeysuckle, agrimony, etc. It is famous for its effects of promoting blood circulation, dredging collaterals, reducing thirst and lowering glucose.The participants in this arm use cream.
Study NCT04706559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Probiotic sachet containing mixture of four strains i.e.Lactobacillus rhamnosus, Lactobacillus acidophilus, Bifidobacterium longum, and Saccharomyces boulardii
Description: Interventional group: Children with AD meeting eligibility criteria receiving probiotics and conventional treatment (topical corticosteroid, topical tacrolimus, an oral antihistamine and emollients).
Study NCT05519865 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Tislelizumab
Description: 200 mg intravenously (IV) Q3W
Study NCT05519865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tislelizumab
Description: 200 mg intravenously (IV) Q3W
Study NCT04706559 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Conventional treatment
Description: topical corticosteroid, topical tacrolimus, an oral antihistamine and emollients as per atopic dermatitis treatment guidelines.
Study NCT04706559 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: topical corticosteroid, topical tacrolimus, an oral antihistamine and emollients as per atopic dermatitis treatment guidelines.
Study NCT06609135 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sentec LuMon Device (EIT system)
Description: Sentec EIT belts will be placed on infants up to once daily from consent through NICU discharge.
Study NCT06609135 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sentec Digital Monitoring System (transcutaneous CO2 monitor)
Description: Sentec transcutaneous CO2 monitors will be placed on infants concurrently with EIT belts.
Study NCT06611215 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Treatment
Description: Prebiotic 1 - Stick pack of combination 1 of two polysaccharides mixed with a glass of water each morning
Study NCT06611215 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 1 - stick pack of maltodextrin 1 mixed with a glass of water each morning
Study NCT06611215 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Treatment
Description: Prebiotic 2 - Stick pack of combination 2 of two polysaccharides mixed with a glass of water each morning
Study NCT06611215 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo 2 - stick pack of maltodextrin 2 mixed with a glass of water each morning
Study NCT06610773 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: hUC-MSCs
Description: 1×10\^6/Kg hUC-MSCs (suspended in 100 mL normal saline containing 5% albumin) are infused intravenously to patients at a controlled rate of 60-80 drops/min.
Study NCT06610773 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Saline+albumin
Description: Normal saline containing 5% albumin had a similar suspension and appearance package to hUC-MSCs, but no MSCs
Study NCT06610513 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided imagery
Description: First meeting: The women will be introduced to the clinic, the purpose of the study will be explained, and a written consent form will be filled out. A Personal Information Form and the Pregnancy Stress Assessment Scale (GSDS-36) and the Richard-Campbell Sleep Scale will be filled out. After the questionnaires are filled out, the vital signs of the pregnant woman will be measured and then a 15-minute guided imagery video will be shown. The vital signs of the patient will be measured again 10 minutes after the guided imagery video is watched.
Study NCT04801212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stability exercises with teeth clenching
Description: The intervention frequency will be 2 sessions per week for the duration of 6 weeks, comprising of 45 minutes session. Both groups will receive heat pack on lumbar spine for 12 minutes and both interventions will be held under the supervision of qualified Musculoskeletal Physiotherapists. During intervention and after 6 weeks of intervention.
Study NCT04801212 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: core stability exercises
Description: The intervention frequency will be 2 sessions per week for the duration of 6 weeks, comprising of 45 minutes session. Both groups will receive heat pack on lumbar spine for 12 minutes and both interventions will be held under the supervision of qualified Musculoskeletal Physiotherapists. During intervention and after 6 weeks of intervention.
Study NCT04801212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: core stability exercises
Description: The intervention frequency will be 2 sessions per week for the duration of 6 weeks, comprising of 45 minutes session. Both groups will receive heat pack on lumbar spine for 12 minutes and both interventions will be held under the supervision of qualified Musculoskeletal Physiotherapists. During intervention and after 6 weeks of intervention.
Study NCT05619133 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PBM
Description: In this study, the health benefits of the addition of NIR to the light spectrum of a desk lamp already available in the market will be investigate; Ikea Ypeperlig, to which a module with high power Lumileds NIR-Leds will be attached with beam angle of 90 degrees. They will be attached in such a way that, when the lamp is installed in the right place, a 1sr beam that covers the users face, neck and hands and lower arms on the desk with the required intensity of 5mW/cm2 of NIR at the skin surface.~The device will be equipped with 3 sensors:~1. A distance sensor connected to the driver of the NIR-leds, such that when the user leans forward or backward, the intensity of the NIR is automatically adjusted such that the intensity on the skin remains 5mW/cm2 (see figure below).~2. a presence sensor~3. ambient vertical lux sensor by which amount of light that enters the users' eye will be measured since it is known that these have an effect sleep, mood and performance.